ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

NLTX Neoleukin Therapeutics Inc

3.49
0.00 (0.00%)
2024年5月7日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Neoleukin Therapeutics Inc NLTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 3.49 09:00:00
始値 安値 高値 終値 前日終値
3.49 3.49
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0719:20EDGAR2Form 8-K - Current report
2024/4/2703:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/4/2703:33EDGAR2Form ARS - Annual Report to Security Holders
2024/4/2703:33EDGAR2Form DEF 14A - Other definitive proxy statements
2024/4/2305:44EDGAR2Form 8-K - Current report
2024/4/0304:43EDGAR2Form 8-K - Current report
2024/3/1905:10EDGAR2Form 8-K - Current report
2024/3/1905:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/1509:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1509:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1509:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0806:29EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0508:20EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0421:30EDGAR2Form 8-K - Current report
2024/2/2206:07EDGAR2Form 8-K - Current report
2024/2/2106:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1508:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1506:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1505:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1423:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0706:18EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1909:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0521:11EDGAR2Form 8-K - Current report
2023/12/2708:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/2708:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/2708:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/2708:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/2708:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/2306:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/2206:05EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/12/1921:31EDGAR2Form 8-K - Current report
2023/12/1509:00GLOBENeoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
2023/12/0706:24EDGAR2Form 425 - Prospectuses and communications, business..
2023/12/0706:21EDGAR2Form 8-K - Current report
2023/12/0507:14EDGAR2Form 425 - Prospectuses and communications, business..
2023/12/0507:10EDGAR2Form 8-K - Current report
2023/12/0106:06EDGAR2Form 425 - Prospectuses and communications, business..
2023/11/0904:34EDGAR2Form S-4/A - Registration of securities, business..
2023/10/1905:09EDGAR2Form S-4/A - Registration of securities, business..
2023/10/0601:50EDGAR2Form 425 - Prospectuses and communications, business..
2023/9/2905:28EDGAR2Form S-4/A - Registration of securities, business..
2023/9/2221:03EDGAR2Form 8-K - Current report
2023/9/2221:00GLOBENeoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
2023/8/1505:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock